At a glance
ClinicalIndex Comparison RecordN/ACompleted· 4,817 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Severity of Newly Diagnosed Asthma Patients and the Result of Initial 12 Weeks Treatment in China.
In Brief
An observational study for Asthma. Completed, enrolled 4,817 participants across 30 sites.
Detailed Summary
The primary objective of the NIS is to evaluate the severity of newly diagnosed asthma patients based on Global Initiative for Asthma (GINA) severity category (GINA 2006 update).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMay 2014
Enrollment StartJun 2014
Primary CompletionSep 2016
TodayJul 2026
First PostedMay 21, 2014
Enrollment StartJun 7, 2014
Primary CompletionSep 15, 2016
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 12.1 years ago